The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab versus best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum.
 
Alexandra Leary
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Tesaro (Inst); zentalis
Research Funding - Inivata (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Elise Deluche
Honoraria - Fresenius Kabi; GlaxoSmithKline; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Lilly; Novartis
Research Funding - AstraZeneca/Daiichi Sankyo (Inst)
Travel, Accommodations, Expenses - Amgen; GlaxoSmithKline; Novartis; Novartis/Ipsen; Pfizer; Roche/Genentech
 
Laure Favier
No Relationships to Disclose
 
Xavier Paoletti
Consulting or Advisory Role - Daiichii Sankyo; MSD Oncology
 
Laura Mansi
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Daiichi Sankyo; Novartis; Roche; Sandoz-Novartis
Research Funding - The Fondation ARC
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Pierre Fabre; Roche; Sandoz-Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Lauriane Eberst
No Relationships to Disclose
 
Thibault De La Motte Rouge
Honoraria - AstraZeneca; Mylan; Pfizer; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; GlaxoSmithKline; Ipsen; Janssen
 
Alain Lortholary
Honoraria - AstraZeneca; clovis oncology; Roche; Tesaro/GSK; Tesaro/GSK
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Frederik Marmé
Honoraria - AGENDIA; Amgen; AstraZeneca; Celgene; Clovis Oncology; Clovis Oncology; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Lilly; MSD Oncology; Myriad Genetics; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche/Genentech; Seagen; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); CureVac; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Pfizer; Roche (Inst); Tesaro; Vaccibody (Inst)
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Tesaro (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Toon Van Gorp
Consulting or Advisory Role - AstraZeneca (Inst); Eisai Europe (Inst); GlaxoSmithKline (Inst); MSD/Merck (Inst); OncXerna Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Immunogen (Inst); MSD/Merck (Inst); PharmaMar (Inst)
 
Anne Floquet
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca/Merck; GlaxoSmithKline; MSD Oncology; PharmaMar
Other Relationship - AstraZeneca/Merck; GlaxoSmithKline
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Novartis; Pfizer; Roche; Seagen